Stockscreener 앱 받기
1.49
0.00%
0.00
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Quarterly Trades: Can Heron Therapeutics Inc expand into new marketsStock Surge & Verified Momentum Stock Ideas - baoquankhu1.vn
VIX Spike: Is Heron Therapeutics Inc affected by consumer sentimentEarnings Growth Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Aug Drivers: Is Heron Therapeutics Inc stock vulnerable to regulatory risksEntry Point & Smart Money Movement Alerts - Bộ Nội Vụ
Heron rises as preliminary revenue figures exceed estimates - MSN
Returns Recap: Does Heron Therapeutics Inc stock trade at a discount to peers - Bộ Nội Vụ
Great week for Heron Therapeutics, Inc. (NASDAQ:HRTX) institutional investors after losing 10% over the previous year - simplywall.st
Heron Therapeutics’ Q4 Earnings Beat Forecasts, Boosted by Acute Care Success - timothysykes.com
HC Wainwright Reaffirms Buy Rating for Heron Therapeutics (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ Revenue Soars Beyond Expectations in Q4 2025 - StocksToTrade
Heron Therapeutics Revenue Exceeds Estimates with Strong Acute Care Performance - StocksToTrade
Heron Therapeutics Surpasses Revenue Expectations with Significant Growth - timothysykes.com
Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M - Yahoo Finance
How supply chain issues affect Heron Therapeutics Inc. stockMarket Sentiment Review & Real-Time Stock Movement Alerts - Улправда
How Heron Therapeutics Inc. stock reacts to global recession fears2025 Price Momentum & Daily Profit Focused Stock Screening - Улправда
Can Heron Therapeutics Inc. stock surprise with earnings upsideCEO Change & Real-Time Buy Signal Alerts - Улправда
Heron Therapeutics Expands Strategic Vision Amid Market Fluctuations - StocksToTrade
Heron Therapeutics Reports Strong Preliminary Q4 2025 Revenue - TipRanks
HRTX: HC Wainwright & Co. Reiterates Buy Rating with $6 Price Ta - GuruFocus
Heron Therapeutics' (HRTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Heron Therapeutics stock soars after strong Q4 revenue growth By Investing.com - Investing.com Canada
Heron Therapeutics announces preliminary, unaudited Q4 results - marketscreener.com
Heron Therapeutics Reports Preliminary Fourth Quarter and Full-Year 2025 Financial Results - Quiver Quantitative
Heron Therapeutics Announces Preliminary, Unaudited Q4 and - GlobeNewswire
Will Heron Therapeutics Inc. stock gain from strong economy2025 Key Lessons & Long-Term Growth Stock Strategies - Улправда
What technical signals suggest for Heron Therapeutics Inc. stock2025 Retail Activity & Daily Profit Maximizing Tips - Улправда
Does Heron Therapeutics Inc. stock trade at a discount to peers2025 Bull vs Bear & High Yield Stock Recommendations - Улправда
How analysts rate Heron Therapeutics Inc. stock todayWeekly Gains Summary & Verified Momentum Stock Alerts - Улправда
Will Heron Therapeutics Inc. stock maintain dividend yield2025 Volatility Report & Long Hold Capital Preservation Tips - Улправда
Can Heron Therapeutics Inc. stock sustain market leadershipIndustrial Stocks Review & High Profit Growth Stocks - ulpravda.ru
Will Heron Therapeutics Inc. stock outperform tech sector in 20252026 world cup usa national team group stage star players high defensive line tactical prediction insights - Улправда
Is Heron Therapeutics Inc AXD2 a good long term investmentConsumer Goods Stocks & Small Capital Gains - earlytimes.in
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Exit Recap: Does Heron Therapeutics Inc stock trade at a discount to peers2025 Market WrapUp & Verified Momentum Watchlists - Bộ Nội Vụ
What analysts say about Heron Therapeutics Inc AXD2 stockContrarian Investment Ideas & High Return Investment Growth - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Investor Mood: Will Heron Therapeutics Inc stock outperform tech sector in 2025Bear Alert & Long Hold Capital Preservation Tips - moha.gov.vn
Is Heron Therapeutics Inc. stock attractive for income investorsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Is Heron Therapeutics Inc. stock cheap at current valuationJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - DonanımHaber
Can Heron Therapeutics Inc. stock sustain revenue growthJuly 2025 Review & Growth Focused Stock Reports - Улправда
Is Heron Therapeutics Inc. stock gaining market shareInflation Watch & Community Consensus Trade Alerts - Улправда
Heron Therapeutics Earnings Notes - Trefis
Is Heron Therapeutics Stock Built to Withstand More Downside? - Trefis
Congress Park Capital LLC Acquires 621,908 Shares of Heron Therapeutics, Inc. $HRTX - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Appoints Thomas Cusack to Board - MSN
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
4.73%
0.92%
자본화:
|
볼륨(24시간):